0013sek
0,0 %
Date:2025-05-14Time:16:49:49Latest report:Q1-2025List:NGMTicker:DIABIO
Market Cap:16 msekEnterprise Value:11 msekNet Sales:0,25 msekEarnings:-9,47 msekEmployees:0ISIN:SE0015961826

Ratios

10-year key figure history for Diagonal Bio turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Diagonal Bio with index and moving average MA50 and MA200.

Stockprice:0,013
MA50:0,01
MA200:0,02
Price/MA200:-41,1 %
RSI (14):44,9
Price/MA50:-6,5 %

Description

Diagonal Bio operates in the biotechnology industry. The company is developing a platform under the name Panviral to detect and diagnose small sections of pathogen genomes, such as viruses, bacteria, and fungi. In addition to the main business, service and associated ancillary services are also offered. The largest operations take place in Sweden with headquarter in Lund.

Biotechnology